Intellectual Property and Public Health in the Developing World
|List of Tables
Volltext
2.1 |
Patent applications and granted patents in Bangladesh (1995–2012) |
42 |
2.2 |
Mailbox applications (pharmaceutical and agrochemical products) |
43 |
2.3 |
The DGDA controls the quality of medicines produced in Bangladesh |
48 |
2.4 |
Changes required for TRIPS-compliant pharmaceutical regulation in Bangladesh |
58 |
2.5 |
Allopathic pharmaceutical companies in Bangladesh |
61 |
2.6 |
The top 10 pharmaceutical companies in Bangladesh (2014) |
62 |
2.7 |
Multinational pharmaceutical companies operating in Bangladesh |
63 |
2.8 |
Pharmaceutical exports from Bangladesh (1975–2006) |
65 |
2.9 |
Survey results regarding whether Bangladesh has the capacity to produce new medicines |
71 |
2.10 |
Survey results on whether TRIPS has influenced the rise in pharmaceutical prices |
75 |
2.11 |
Top 10 drugs in terms of sales in Bangladesh |
76 |
2.12 |
Changes in retail price of 10 important drugs |
77 |
2.13 |
Causes of death in Bangladesh |
78 |
2.14 |
Diseases prevalent in Bangladesh |
79 |
3.1 |
Policy options used by Brazil, India and South Africa |
144 |
Nur der Text ist unter der Lizenz CC BY 4.0 nutzbar. Alle anderen Elemente (Abbildungen, importierte Anhänge) sind „Alle Rechte vorbehalten“, sofern nicht anders angegeben.